Acute paraproctitis: clinical guidelines

Applies toadults, children2024 editionK61, K61.0, K61.1, K61.2…

Clinical guidelines of the Russian Ministry of Health, adults, children. 2024 edition, ICD-10 codes: K61, K61.0, K61.1, K61.2….

Receive research articles on "Acute paraproctitis"Every morning — fresh PubMed studies on this topic and specialty: in English, with figures, sample sizes, and conclusions. Plus updates to Russian clinical guidelines.

Subscribe for 990 ₽

Brief for Practice

WhiteCoat Pro editorial summary based on the 2024 guideline text. Each item links to the original section — verify against it before prescribing.

Acute paraproctitis is an acute inflammation of the pararectal cellular tissue caused by the spread of a purulent-inflammatory process from the anal crypts and anal glands. The primary cause is mixed intestinal microflora, most commonly represented by aerobic microorganisms. This guideline focuses on the diagnosis and treatment of aerobic acute paraproctitis; anaerobic paraproctitis is not covered.

Key points

Diagnostics

  1. Assess pain or discomfort in the anus and perineum, swelling, difficulty with defecation or urination, local skin hyperthermia, and possible lower abdominal pain. Collect history regarding immunodeficiency, diabetes, constipation or diarrhea, cryptitis, anal fissure, and prior anorectal surgeries. → in text
  2. Inspect and palpate the perianal, sacrococcygeal, and gluteal regions, assess the extent of inflammation, and perform a digital rectal examination (level of confidence C, level of reliability of evidence 5). The examination checks for crypt tenderness, bulging or infiltration of the rectal wall, and signs of deep forms of acute paraproctitis. → in text
  3. Order laboratory tests to identify comorbidities and conditions; there is no specific laboratory test for acute paraproctitis. In extensive inflammation, a complete blood count may reveal leukocytosis. → in text
  4. In cases of unclear or atypical clinical presentation or undefined inflammatory boundaries, perform transrectal ultrasound of the rectum or soft tissue ultrasound (level of confidence C, level of reliability of evidence 5). Transrectal examination evaluates the dimensions and location of the cavity, as well as involvement of the bowel wall and sphincter apparatus. → in text
  5. Pelvic MRI is indicated for unclear or atypical presentations, undefined inflammatory boundaries, suspected extensive tracking, or high-seated abscesses (level of confidence B, level of reliability of evidence 3). Transrectal ultrasound is not recommended for children with acute paraproctitis due to the mismatch between the probe size and the anal canal (level of confidence C, level of reliability of evidence 5). → in text
  6. Differential diagnosis excludes suppurative diseases of the perineal and gluteal skin, bartholinitis, presacral cysts with an inflammatory component, trauma, teratomas, anaerobic paraproctitis, rectal tumors, Crohn's disease or ulcerative colitis complicated by abscess, diverticular disease complicated by abscess, and radiation therapy complications. → in text

Treatment

When to refer and how to monitor

Frequently asked questions

Is an MRI necessary for every patient with acute paraproctitis?

No. In most cases, a clinical examination is sufficient. Pelvic MRI is performed in atypical or unclear presentations, undefined inflammatory boundaries, suspected extensive tracking, or high-seated abscesses; ultrasound is used for similar uncertainties. → in text

Can acute paraproctitis be treated with antibiotics alone?

The primary treatment is surgical opening and drainage of the abscess. Antibiotics are added in cases of widespread inflammation, sepsis, immunodeficiency states, and associated diseases. → in text

When is a radical operation performed after abscess opening?

When the affected crypt is clearly identified and there is an intrasphincteric or transsphincteric tract involving less than 30% of the external sphincter, the tract is excised into the intestinal lumen. → in text

What should be done in case of neutropenia and suspected paraproctitis?

Prescribe empirical intravenous antibiotics with activity against gram-negative bacteria, including Pseudomonas aeruginosa. In confirmed abscess or necrosis, perform opening and drainage; in severe neutropenia without an abscess, antibiotic therapy is used. → in text

When can a patient be managed in a day-care unit?

This is possible with subcutaneous or submucosal localization of the abscess, provided there is no general intoxication, decompensation of comorbid conditions, neutropenia, or verified Crohn's disease. → in text

Status
Applied · approved by the Scientific and Practical Council of the Russian Ministry of Health
Database ID
185, edition 3 (ID 185_3)
Publication date
August 2, 2024
Age category
adults, children
ICD-10 codes
K61K61.0K61.1K61.2K61.3K61.4
Specialties
Pediatric SurgeryColoproctology
Developers
All-Russian Public Organization "Association of Coloproctologists of Russia"
All-Russian Public Organization "Russian Association of Pediatric Surgeons"
Official text
Russian Ministry of Health Rubricator — 185_3

List of Abbreviations

IBD – inflammatory bowel disease

IAP – internal anal sphincter

MRI – magnetic resonance imaging

AP - acute paraproctitis

AF - anal fistula

TRUS – transrectal ultrasound

Terms and Definitions

An anal fistula is a pathological tract between the anal canal and the surrounding tissues and/or organs and/or the perianal skin.

Anal crypts (Crypts of Morgagni) are small depressions between the longitudinal mucosal folds (Columns of Morgagni), located directly above the dentate line in the upper third of the anal canal.

Anaerobic paraproctitis is an infection caused by clostridial species, characterized by an extremely severe clinical course.

1. Brief information on the disease or condition

1.1 Definition of the disease or condition

Acute paraproctitis (AP) is an acute inflammation of the perirectal cellular tissue caused by the spread of a purulent-inflammatory process from the anal crypts and anal glands. The primary cause of AP is mixed intestinal microflora, most commonly represented by aerobic microorganisms [1-5].

Anaerobic paraproctitis is a distinct, life-threatening condition associated with a high mortality rate that requires completely different diagnostic and therapeutic approaches compared to acute aerobic paraproctitis and is not covered in these clinical guidelines.

1.2 Etiology and pathogenesis of the disease or condition (group of diseases or conditions)

Cryptogenic paraproctitis is the most common in clinical practice (about 90%), whereas paraproctitis secondary to other conditions—such as inflammatory bowel disease, tumors, pelvic cysts, teratomas, trauma, and radiation injury—is less frequent. The development of AP is driven by several predisposing factors: immunosuppression, microcirculatory disorders, gastrointestinal disturbances, and complications of hemorrhoids, anal fissures, or cryptitis. In pediatric patients, primary immunodeficiency states can be the cause of acute paraproctitis. Additionally, a congenital theory is considered, based on the concept of androgen-estrogen imbalance or excessive androgenic stimulation of the mucosal glands, which makes the crypts of Morgagni 1-2 mm deeper than usual [1-3,5-9].

1.3 Epidemiology of the Disease or Condition

AP is the most common condition in emergency proctology practice. Patients in this group account for about 1% of all admissions to surgical inpatient units and 5% of those suffering from colonic and rectal disorders [10,11]. Overall, the incidence of acute paraproctitis among the adult population is 16.1-20.2 per 100,000 [4,12,13]. From 2% to 7% of all pediatric surgical conditions requiring inpatient care are accounted for by patients with acute paraproctitis; AP can occur in any pediatric age group, but it overwhelmingly predominates in infants during their first months of life at 22-60% [14].

1.4 Features of Coding the Disease or Condition

ICD-10 Codes

Chapter – Diseases of the digestive system (XI).

Block – Abscess of anal and rectal regions (K61).

Code:

K61.0 Anal abscess

K61.1 - Rectal abscess

K61.2 - Anorectal abscess

K61.3 - Ischiorectal abscess

K61.4 - Intrasphincteric abscess

1.5 Classification of the disease or condition

By the localization of the lesion relative to anatomical landmarks:

a) subcutaneous;

b) submucosal;

c) intersphincteric;

d) ischioanal;

e) pelvirectal:

- pelvirectal;

- retrorectal.

By the localization of the inflammatory focus according to the conventional clock face:

a) posterior (from 4 to 8 o'clock on the conventional clock face);

b) anterior (from 10 to 2 o'clock on the conventional clock face);

c) lateral (from 8 to 10 o'clock or from 2 to 4 o'clock on the conventional clock face);

d) horseshoe (when the inflammation spreads to more than one of the zones listed above).

By the nature of the purulent tract (identified intraoperatively):

a) intrasphincteric;

b) transsphincteric;

c) extrasphincteric.

1.6 Clinical presentation of the disease or condition

The clinical presentation depends on the severity, localization, and extent of the inflammatory process. Subcutaneous paraproctitis presents as a dense, tender infiltrate in the perianal area with overlying skin hyperemia, which may have an area of fluctuation. Pain worsens during defecation, sitting, coughing, and walking. Symptoms of systemic toxicity are usually absent.

Submucosal paraproctitis manifests as pain during defecation and a low-grade fever; systemic toxicity symptoms are usually absent.

In infants, subcutaneous and submucosal localizations of acute paraproctitis predominate.

In ischioanal paraproctitis, in addition to pain, gluteal asymmetry is found, with skin hyperemia appearing in a delayed manner on days 5-6.

Ischioanal paraproctitis is accompanied by symptoms of systemic toxicity in the first days of the disease, followed by local changes in the perianal region: gluteal asymmetry, induration, and perianal skin hyperemia.

Pelvirectal paraproctitis has the most severe clinical course, dominated by pronounced symptoms of systemic toxicity (malaise, weakness, sleep disturbances, severe night sweats, chills, febrile temperature, headaches, dizziness). Pain in the lower abdomen may also occur. Indefinite symptoms persist on average for up to 12 days, followed by discomfort and pain in the anal canal during defecation, difficult bowel emptying, urinary hesitation, and possibly pain in the lower extremity on the side of the AP along the nerve pathways. Upon palpation, men may feel an urge to urinate due to the proximity of the infiltrate to the urethra [1,15-19].

2. Diagnostics, medical indications and contraindications for diagnostic methods

Criteria for establishing the diagnosis/condition — based on clinical examination data and, if necessary, instrumental diagnostics.

Differential diagnosis of AP caused by primary inflammation in the anal crypt area is performed with conditions such as:

1. Purulent-inflammatory diseases of the perineal, sacrococcygeal, and gluteal skin.

2. Bartholinitis.

3. Presacral cysts with an inflammatory component.

4. Perianal trauma.

5. Teratomas.

6. Anaerobic paraproctitis.

7. Rectal tumors.

8. Crohn's disease, ulcerative colitis complicated by an abscess.

9. Diverticular disease complicated by an abscess.

10. Complications of radiation therapy.

Principles of formulation of the diagnosis.

When formulating the diagnosis, the localization of the inflammatory process should be indicated. Examples of diagnosis formulations are given below:

1. Acute anterior horseshoe paraproctitis.

2. Acute posterior pelvirectal paraproctitis.

3. Acute retrorectal paraproctitis.

2.1 Complaints and Anamnesis

Characteristic complaints: discomfort and/or pain in the anus and perineum, worsening as the inflammatory process progresses; presence of a swelling in the soft tissues of the perianal, perineal, or gluteal region; difficulty with defecation and/or urination; local elevation of skin temperature over the inflammatory focus; and possible onset of lower abdominal pain [1,9,10].

The medical history may reveal:

· Immunosuppression due to a concurrent acute or chronic infection

· Hypothermia

· Vascular alterations secondary to diabetes mellitus

· Gastrointestinal disturbances (constipation and/or diarrhea)

· Cryptitis

· Anal fissure

· Primary or secondary immunodeficiency states (HIV infection)

· Previous anorectal or perineal surgical interventions.

2.2 Physical Examination

It is recommended that patients with suspected acute paraproctitis undergo inspection and palpation of the perianal, sacrococcygeal, and gluteal regions, as well as a digital rectal examination [1, 19-21].

GCP CLEL 5Grade of Recommendation – C (Level of Evidence – 5).

Comment. Clinical examination and digital rectal examination are performed with the patient in the gynecological position for lithotomy or in the knee-chest position.

Standard clinical examination includes inspection of the perineum and anus, assessing the severity and extent of the inflammatory process.

Standard digital rectal examination can determine:

- localization of the inflamed crypt (tenderness of the wall) on the side of the infiltrate;

- bulging of the rectal wall, pain, and smoothing of folds on the affected side;

- in retrorectal paraproctitis — bulging in the posterior rectal wall area, as well as increased pain upon pressure on the coccyx;

- in pelviorectal paraproctitis — tenderness of one of the rectal walls, infiltration of the intestinal wall, or a dense infiltrate beyond it. In later stages, thickening of the bowel wall is determined, its displacement from the outside, followed by bulging of an elastic, sometimes fluctuating formation into the lumen, over which the intestinal mucosa may remain mobile. When the inflammation spreads to the prostate gland and urethra, palpation of the rectal wall causes painful urinary urgency [1, 20].

2.3 Laboratory Diagnostics

Specific laboratory diagnostics for acute paraproctitis are lacking. Laboratory diagnostic tests should be performed in patients during the diagnosis and treatment of acute paraproctitis to exclude concomitant diseases and conditions. In a complete blood count, leukocytosis may be determined in the presence of extensive inflammatory lesions.

2.4 Instrumental Diagnostics

In most cases, instrumental diagnostics are not required to diagnose acute paraproctitis.

It is recommended that patients undergo transrectal ultrasound of the rectum or ultrasound of soft tissues in case of an unclear and atypical clinical presentation or absence of clear boundaries of the spread of the inflammatory process [21-27]

GRS CLEL 5Grade of recommendation – C (level of evidence – 5

Comment: transrectal ultrasound of the rectum is performed to assess the localization and size of the purulent cavity, the degree of involvement of the rectal wall and the anal sphincter complex in the inflammatory process [24-27]. The diagnostic accuracy of ultrasound reaches 90% [24].

It is not recommended to perform transrectal ultrasound of the rectum in pediatric patients with acute paraproctitis due to the mismatch between the probe size and the anal canal [15, 28].

GCP CLEL 5Grade of Recommendation – C (Level of Evidence – 5)

It is recommended that patients with acute paraproctitis undergo magnetic resonance imaging (MRI) of the pelvic organs in case of an unclear and atypical clinical presentation, absence of clear boundaries of the spread of the inflammatory process, or suspected extensive fluid collections and high abscess location [24, 26, 27, 29, 30].

Level of Evidence BGrade of Recommendation 3Level of Clinical Effectiveness – B (level of evidence – 3)

Comment: MRI provides anatomical detail and is a non-contact imaging method. Disadvantages of the method include high cost, the need for an MRI specialist, and long acquisition time.

2.5 Other Procedures

Microbiological (culture) examination of purulent discharge for aerobic and facultatively anaerobic microorganisms is not a mandatory diagnostic method, but it is advisable for determining further treatment tactics, and for excluding/confirming anaerobic or other specific bacterial flora. It consists of identifying the microflora species of the purulent focus to clarify the diagnosis and administer adequate antibiotic therapy. Material is collected in the operating room during abscess puncture [5, 31, 32].

3. Treatment, including drug and non-drug therapies, diet therapy, and pain management

3.1 General Principles of Acute Paraproctitis Treatment

The main method of treatment for acute paraproctitis is surgical.

Surgery should be performed within the first few hours after diagnosis verification.

The goal of surgery is the opening and drainage of the abscess, searching for and, if possible, eliminating the affected crypt and purulent tract [1, 33-40].

Indications for hospitalization: a verified diagnosis of acute paraproctitis [3, 10].

The type of surgical intervention depends on the localization of the abscess and the extent of the inflammatory infiltrate in the surrounding tissues [1, 33-38].

In infants, the possibility of conservative treatment for subcutaneous paraproctitis is considered. Opening of acute paraproctitis must be performed if there is a likelihood of abscess spread [41-45].

Recommended antibiotic therapy (systemic antibacterial drugs) in the perioperative period in cases of significant spread of the inflammatory process, sepsis, immunodeficiency states, and diseases [46-50].

For adults: Grade of recommendation – B (level of evidence – 1).

For children: Grade of recommendation – C (level of evidence – 4).

3.2 Opening of Acute Purulent Paraproctitis

It is recommended for all patients with diagnosed acute paraproctitis to undergo opening and drainage of the abscess to prevent the development of purulent-septic complications [16, 51-53].

GCR ALEL 2Grade of Recommendation – A (Level of Evidence – 2)

Comment. If clear verification of the affected crypt is absent, the surgical intervention is limited to opening and drainage of the abscess.

Opening and drainage of subcutaneous and ischioanal acute paraproctitis.

Method: A semilunar incision is made on the affected side, in the central part of the abscess, cutting through the skin and subcutaneous tissue. Abscess drainage is performed in such a way that no pockets remain deep in the wound and drainage is adequate. For this purpose, the skin wound is widened and drained.

Opening and drainage of pelviorectal acute paraproctitis.

Method: A semilunar incision is made on the affected side, at least 3 cm away from the anal verge, cutting through the skin, subcutaneous, and ischioanal tissue. A longitudinal incision is made through the muscle tissue of the pelvic diaphragm. This manipulation must be performed under visual control. If it cannot be performed under direct vision, muscle splitting can be performed bluntly — with a finger, clamp blades, or a Bozeman forceps. Abscess drainage is performed in such a way that no pockets remain deep in the wound and drainage is adequate.

Opening and drainage of retrorectal paraproctitis.

Indications: abscesses localized in the retrorectal space.

Method: An incision of the skin is made midway between the projection of the coccyx tip and the posterior edge of the anal opening, up to 5 cm in length. After evacuation of pus, the wound is treated with antiseptic solutions. The edge of the wound adjacent to the bowel wall is retracted using a hook to properly expose the posterior wall of the anal canal surrounded by the sphincter muscles.

Opening and drainage of horseshoe paraproctitis.

Method: The scope of surgical intervention depends on the location of the abscess relative to the sphincter muscles.

3.3 Opening and drainage of acute paraproctitis, excision of the affected crypt, placement of an elastic draining setton

It is recommended for patients after opening of acute paraproctitis with clear verification of the affected crypt with a transsphincteric (involving more than 30% of the sphincter) or extrasphincteric location of the purulent tract, for better drainage and wound healing, prevention of acute paraproctitis recurrence and postoperative complications, as well as for preparation for radical surgery, to excise the affected crypt and place an elastic draining setton through the affected crypt and skin wound [7, 8, 39, 52, 53].

GCR CLOE 5Grade of Recommendations – C (Level of Evidence – 5).

Comment.

Method: A wide semilunar skin incision is made on the affected side; then, after evacuation of pus and discovery of the purulent tract, the incision is extended to the midline. From the lumen of the intestine, a circumscribing incision is made around the affected crypt, extending along the entire length of the anal canal until it connects with the corner of the perineal wound. A narrow strip of the anal canal lining and perianal skin is excised. Through the opening at the site of the removed crypt, an elastic drain is passed, one end of which is brought out of the perineal wound at the midline, and the other through the internal opening in the bowel lumen. The ends of the drain are connected to each other and fixed together with a ligature. The drain must not compress or cut through the involved tissues. The elastic draining setton should not be removed until a consolidated fistula has formed [52, 53].

3.4 Radical Surgeries in Acute Paraproctitis

It is recommended that all patients following the drainage of acute paraproctitis, upon clear verification of the affected crypt with an intersphincteric or transsphincteric course of the purulent tract (involving less than 30% of the external sphincter portion), undergo radical excision of the fistulous tract into the lumen of the rectum [52,53-56].

GRL ALEL 2Grade of Recommendation – A (Level of Evidence – 2).

Commentary.

Procedure: An examination of the anal canal is performed to locate the affected crypt of the internal fistula opening. A dye test is used to clearly visualize the purulent cavity and detect the affected crypt. A probe with a button end is used to clarify the position of the tract relative to the sphincter fibers. After this, a wide semi-lunar skin incision is made on the affected side, followed by cutting the purulent tract into the rectal lumen and excising the affected anal crypt. The probability of acute paraproctitis recurrence is up to 6% [53].

3.5 Treatment of Acute Paraproctitis in Neutropenia

Neutropenia significantly alters the clinical presentation and course of infectious processes in tissues. Abscess formation under conditions of neutropenia is rare; tissue changes more commonly present as inflammatory infiltrates and necrosis [57-61]. Acute paraproctitis developing against the background of granulocytopenia is a severe complication associated with a high probability of sepsis (30%) under immunosuppression [60,61].

It is recommended that all patients with acute paraproctitis and neutropenia be prescribed empirical antibiotic therapy regimens to halt the progression of anorectal infection and the development of sepsis [47,58,59].

Level of Evidence CGrade of Recommendation 4Level of Evidence – C (Grade of Recommendation – 4).

Commentary. It is advisable at the initial stage to use antibiotics (J01: Antibacterials for systemic use) active against gram-negative bacteria, including Pseudomonas aeruginosa. Administration of antibiotics (J01: Antibacterials for systemic use) must be intravenous only [51].

It is recommended that all patients with neutropenia and confirmed abscess or tissue necrosis undergo incision and drainage of acute paraproctitis [57-63].

Level of Evidence CGrade of Recommendation 4Level of Evidence – C (Grade of Recommendation – 4).

Commentary. Surgical intervention should be performed against the background of antibacterial therapy under general anesthesia. Antibacterial therapy should be continued in the postoperative period until signs of infection disappear [59].

Patients with severe neutropenia (absolute neutrophil count less than 1000x109/L) and no tissue abscess are more successfully treated with antibiotic therapy alone [57,58,62]. The prognosis depends on the clinical situation. The mortality rate directly associated with perianal infectious complications among oncohematological patients in modern studies is less than 5% [57-60].

4. Medical Rehabilitation and Sanatorium-Resort Treatment

It is recommended that all patients who have undergone surgery for acute paraproctitis undergo regular dressings consisting of treating wounds with antiseptic solutions and applying ointments with anti-inflammatory and wound-healing properties to the wound surface until epithelialization. During dressings, monitoring is required to prevent premature adhesion/healing of the skin edges of the wound while inflammation persists in the underlying tissues [14,51].

GOR BLOE 2Grade of Recommendation – B (Level of Evidence – 2).

After discharge from the hospital, for the duration of wound healing, it is advisable for all patients to be followed up by a coloproctologist, surgeon, or pediatric surgeon.

5. Prevention and Dispensary Observation

There is no specific prevention for acute paraproctitis. Prevention of acute paraproctitis mainly consists of general body-strengthening measures aimed at eliminating the etiological factors of the disease:

1) treatment and sanitization of acute and chronic infection foci;

2) management of chronic diseases – diabetes mellitus, atherosclerosis;

3) correction of functional disorders (constipation, diarrhea);

4) timely treatment of concomitant proctological diseases (hemorrhoids, anal fissures, cryptitis, etc.).

6. Organization of Medical Care

Medical care, with the exception of medical care within the framework of clinical trials, in accordance with Federal Law No. 323-FZ dated November 21, 2011 (as amended on December 28, 2022) "On the Fundamentals of Protecting the Health of Citizens in the Russian Federation", and Government Decree of the Russian Federation No. 1968 dated November 17, 2021, "On Approval of the Rules for the Phased Transition of Medical Organizations to the Provision of Medical Care Based on Clinical Guidelines Developed and Approved in Accordance with Parts 3, 4, 6–9, and 11 of Article 37 of the Federal Law 'On the Fundamentals of Protecting the Health of Citizens in the Russian Federation'", is organized and provided:

1) in accordance with the regulations on the organization of medical care by types of medical care, approved by the authorized federal executive body;

2) in accordance with the care standards for the profile "coloproctology", which are mandatory for implementation throughout the Russian Federation by all medical organizations;

3) based on these clinical guidelines;

4) taking into account the standards of medical care approved by the authorized federal executive body.

Hospitalization of patients with acute paraproctitis is carried out on an emergency basis to perform surgical intervention within the first few hours after diagnosis verification. Treatment of this category of patients is carried out in a specialized coloproctological inpatient facility, or in its absence, in a surgical inpatient facility. For subcutaneous and submucosal abscess localization, treatment may be carried out in a day care unit, round-the-clock inpatient unit, or short-stay unit. Treatment in a day care unit and short-stay unit is possible in the absence of signs of general intoxication, absence of signs of decompensation of concomitant diseases, no evidence of paraproctitis against the background of neutropenia, and verified Crohn's disease. Medical care for acute paraproctitis patients is provided by coloproctologists, or in their absence, by surgeons or pediatric surgeons.

Indication for hospitalization:

· confirmed diagnosis of acute paraproctitis.

Indications for patient discharge:

· with sustained improvement, when the patient can continue outpatient treatment without detriment to health under the supervision of a coloproctologist, surgeon, or pediatric surgeon

· in the absence of indications for further inpatient treatment

· if the patient needs to be transferred to another medical institution

· at the request of the patient or their legal representative

· in cases of non-compliance by the patient with prescriptions or internal inpatient rules, provided this does not threaten the life of the patient or the health of others.

7. Additional Information

Negative factors affecting treatment outcomes include:

1. Development of infectious complications.

2. Stool disorders (diarrhea or constipation).

3. Non-compliance by the patient with restrictions on physical activity and exertion.

Criteria for Evaluating the Quality of Medical Care

Criteria for evaluating the quality of primary health care provided to adults with acute paraproctitis

No.

Quality assessment criteria

Evaluation of compliance

1.       

Coloproctologist/surgeon appointment (examination, consultation) performed

Yes/No

2.       

Visual examination of the sigmoid and rectum performed (upon establishing the diagnosis)

Yes/No

3.       

Transrectal digital examination of the rectum performed

Yes/No

Criteria for evaluating the quality of specialized medical care provided to adults with acute paraproctitis

No.

Quality assessment criteria

Evaluation of compliance

1.

Coloproctologist consultation (examination, assessment) performed

Yes/No

2.

Digital rectal examination performed (upon establishment of diagnosis)

Yes/No

3.

Incision of acute paraproctitis performed

Yes/No

4.

Incision and drainage of acute paraproctitis performed (in case of neutropenia and confirmed abscess or necrosis)

Yes/No

5.

Dressings performed in the postoperative period at least once a day until discharge from the hospital (in case of surgical intervention)

Yes/No

References

Show references
  1. Shelygin, Yu.A. Handbook of Coloproctology / Yu.A. Shelygin, L.A. Blagodarny // M.: Litterra. – 2012. – p. 96-114.

  2. Gosselink, M.P. The cryptoglandular theory revisited / M.P. Gosselink, R.S. Onkelen, W.R. Schouten // Colorectal Dis. – 2015. – № 17. – p. 1041-1043.

  3. Sugrue, J. Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review / J. Sugrue, J. Nordenstam, H. Abcarian // Tech Coloproctol. – 2017. – №21(6). – p. 425-432.

  4. Ladinsky, A. Elderly Patients Managed Non-Operatively with Abscesses of the Anorectal Region Have Five Times Higher Rate of Mortality Compared to Non-Elderly / A. Ladinsky, A. Smiley, R. Latifi // Int J Environ Res Public Health. – 2023. – №20(7). – p. 5387.

  5. Guner Ozenen, G. Perianal abscess in children: an evaluation of microbiological etiology and the effectiveness of antibiotics / G. Guner Ozenen, A. Akaslan Kara, A. Ozer, P. Kacar, D. Ergun, et al. // Pediatr Surg Int. – 2023. – №39(1). – р. 272.

  6. Scherbakova, O.V. Primary immunodeficiency states mimicking inflammatory bowel diseases: clinical aspects and differential diagnosis challenges / O.V. Scherbakova // Almanac of Clinical Medicine. – 2023. – Vol. 51. – №8. – p. 456-468.

  7. Gosemann, J-H. Perianal abscesses and fistulas in infants and children / J-H. Gosemann, M. Lacher // Eur J Pediatr Surg. – 2020. – №30(5). – р. 386-390.

  8. Ding, W. Treatment of perianal abscess and fistula in infants and young children: from basic etiology to clinical features / W. Ding, Y-R. Sun, Z-j. Wu // Am Surg. – 2021. – №87(6). – р. 927-932.

  9. Newton, K. PPAC2 Collaborators. Postoperative Packing of Perianal Abscess Cavities (PPAC2): randomized clinical trial / K. Newton, J. Dumville, M. Briggs, et al. // Br J Surg. – 2022. – №109(10). – p. 951-957.

  10. Pearce, L. North West Research Collaborative. Multicentre observational study of outcomes after drainage of acute perianal abscess / L. Pearce, K. Newton, S.R. Smith, et al. // Br J Surg. – 2016. – №103(8). – p. 1063-1068.

  11. Bolkvadze, E.E. Complex forms of acute paraproctitis. Literature review / E.E. Bolkvadze // Coloproctology. – 2009. – №27(1). – p. 38-46.

  12. Sahnan, K. Natural history of anorectal sepsis / K. Sahnan, A. Askari, S.O. Adegbola, et al. //  Br J Surg. – 2017. – №104(13). – p. 1857-1865.

  13. Adamo, K. Prevalence and recurrence rate of perianal abscess-a population-based study, Sweden 1997-2009 / K. Adamo, G. Sandblom, F. Brännström, K. Strigård // Int J Colorectal. – 2016. – №31(3). – p. 669-673.

  14. Geraskin, A.V. Pediatric Coloproctology: A Guide for Physicians / A.V. Geraskin, A.F. Dronov, A.N. Smirnov // M.: "Kontent". – 2012. – 664 p.

  15. Zyuzko, D.D. Acute paraproctitis and pararectal fistulas in children. Literature review / D.D. Zyuzko, O.V. Scherbakova // Russian Journal of Pediatric Surgery, Anesthesiology and Intensive Care. – 2023. – Vol. 13. – №3. – p. 419-430.

  16. Razumovsky, A.Yu. Pediatric Surgery: National Guidelines / ed. by A.Yu. Razumovsky. – 2nd ed., rev. and supp. // M.: "GEOTAR-Media". – 2021. – 280 p.

  17. Kuzmin, A.I. Features of diagnosis and treatment of paraproctitis in children / A.I. Kuzmin, A.G. Munin, M.A. Barskaya et al. // Pediatric Surgery. – 2020 – №24(1). – p. 29-34.

  18. Sigmon, D.F. Perianal Abscess / D.F. Sigmon, B. Emmanuel, F. Tuma // StatPearls [Internet] Treasure Island (FL): StatPearls Publishing. – 2024. – Available from: https://www.ncbi.nlm.nih.gov/books/NBK459167/

  19. Akinmoladun, O. Anal Cryptoglandular Suppuration: Evidence-Based Management / O. Akinmoladun, Q.M. Hatch // Surg Clin North Am. – 2024. – №104(3). – р. 491-501.

  20. Gaertner, W.B. On behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons / W.B. Gaertner, P.L. Burgess, J.S. Davids, et al. // Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula. Diseases of the Colon & Rectum. – 2022. – №65(8). – р. 964-985.

  21. Tan Tanny, S.P. Surgical management of perianal abscess in neonates and infants / S.P. Tan Tanny, N. Wijekoon, R.M. Nataraja, et al. // ANZ J Surg. – 2020. – №90(6). – p. 1034-1036.

  22. Hwang, J.Y. Transperineal ultrasonography for evaluation of the perianal fistula and abscess in pediatric Crohn disease: preliminary study / J.Y. Hwang, H.K. Yoon, W.K., et al. // Ultrasonography. – 2014. – №33(3). – p. 184-190.

  23. Crowley, E. Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn"s Disease Clinical Trials / E. Crowley, C. Ma, L. Guizzetti, et al. // Inflamm Bowel Dis. – 2024. – №30(3). – p. 357-369.

  24. Maconi, G. Transperineal ultrasound for perianal fistulas and abscesses - a systematic review and meta-analysis / G. Maconi, M.T. Greco, A.K. Asthana // Ultraschall Med. – 2017. –  №38(3). – р. 265-272.

  25. Kumar, S. Current update on the role of endoanal ultrasound: a primer for radiologists / S. Kumar, R.K. Chaudhary, S.S. Shah, D. Kumar, P. Nepal, V. Ojili // Abdom Radiol (NY). –  2024.  Published online.

  26. Amato, A. Evaluation and management of perianal abscess and anal fistula: SICCR position statement / A. Amato, C. Bottini, P. De Nardi, et al. // Tech Coloproctol. – 2020. – №24. – p. 127-143.

  27. Nuernberg, D. EFSUMB Recommendations for Gastrointestinal Ultrasound Part 3: Endorectal, Endoanal and Perineal Ultrasound / D. Nuernberg, A. Saftoiu, A.P. Barreiros, et al. // Ultrasound Int Open. – 2019. – №5(1). – p. 34-51.

  28. Ding, Y.W. Can transcutaneous perianal ultrasonography be the first-line diagnostic instrument for evaluating pediatric perianal fistulas? / Y.W. Ding, H.Q. Yin, H.T. Liang, et al. //  Gastroenterol Rep (Oxf). – 2022. – №10 – goac071.

  29. Zinicola, R. Acute supralevator abscess: the little we know / R. Zinicola, N. Cracco, G. Rossi, et al. // Ann R Coll Surg Engl. – 2022. – №104(9). – p. 645-649.

  30. Tabari, A. Clinical characteristics and MRI-based phenotypes of perianal abscess formation in children with fistulizing Crohn"s Disease / A. Tabari, J.L. Kaplan, S.Y. Huh, et al. // Front Pediatr. – 2022. – №10 – 1045583.

  31. Toyonaga, T. Microbiological analysis and endoanal ultrasonography for diagnosis of anal fistula in acute anorectal sepsis / T. Toyonaga, M. Matsushima, Y. Tanaka, et al. // Int J Color Dis. – 2007. – №22. – p. 209-213.

  32. Du, J. No Difference in the Pathogenic Microorganisms Among Different Types of Anorectal Abscesses: A Retrospective Study / J. Du, Y. Miao, S. Zhen, et al. // Cureus. – 2024. – №16(3). – e. 56504.

  33. Vogel, J.D. Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula / J.D. Vogel, E.K. Johnson, A.M. Morris, et al. // Dis Colon Rectum. – 2016. – №59(12). – p. 1117-1133.

  34. Ommer, A. German S3 guidelines: anal abscess and fistula (second revised version) / A. Ommer, A. Herold, E. Berg, et al. // Langenbecks Arch Surg. – 2017. – №402(2). – p. 191-201.

  35. Yamana, T. Japanese Practice Guidelines for Anal Disorders II. Anal fistula / T. Yamana // J Anus Rectum Colon. – 2018. – №2(3). – p. 103-109.

  36. Steele, S.R. Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of perianal abscess and fistula-in-ano / S.R. Steele, R. Kumar, D.L. Feingold, et al. // Dis Colon Rectum. – 2011. – №54(12). – p. 1465-1474.

  37. Pearce, L. Multicentre observational study of outcomes after drainage of acute perianal abscess / L. Pearce, K. Newton, S.R. Smith, et al. // Br J Surg. – 2016. – №103(8). – p. 1063-1068.

  38. Abcarian, H. Anorectal Infection: Abscess–Fistula / H. Abcarian // Clin Colon Rectal Surg. – 2011. – №24(1). – p. 14-21.

  39. Shi, Y. A systematic review and meta-analysis of incision and seton drainage in the treatment of high perianal abscess / Y. Shi, C. Zhi, Y. Cheng, L. Zheng // Ann Palliat Med. – 2021. – №10(9). – p. 9830-9840.

  40. Juth Karlsson, A. Outcomes of Various Interventions for First-Time Perianal Abscesses in Children / A. Juth Karlsson, M. Salö, P. Stenström // Biomed Res Int. – 2016. – 9712854.

  41. Gong, Z. Treatment of First-Time Perianal Abscess in Childhood, Balance Recurrence and Fistula Formation Rate with Medical Intervention / Z. Gong, M. Han, Y. Wu, et al. // Eur J Pediatr Surg. –  2018. – №28(4). – p. 373-377.

  42. Yin, W. Natural course of perianal abscess in infants: a real-world study / W. Yin, Y. Li, J. Zhang, et al. // Sci Rep. – 2023. –№13(1) – 18416.

  43. Christison-Lagay, E.R. Nonoperative management of perianal abscess in infants is associated with decreased risk for fistula formation / E.R. Christison-Lagay, J.F. Hall, P.W. Wales, et al. //  Pediatrics. – 2007. – №120(3). – e548-52.

  44. Kang, C. Intermediate-term evaluation of initial non-surgical management of pediatric perianal abscess and fistula-in-ano / C. Kang, G. Liu, R. Zhang, et al. // Surg Infect (Larchmt). – 2022. – №5(23). – p. 465-469.

  45. Stokes, R. Management of perianal abscesses in infants without general anaesthesia: a systematic review of the literature / R. Stokes, D. Wanaguru, A. Saadi, S. Adams // Pediatr Surg Int. – 2020. – №36(11). – p. 1317-1325.

  46. Sözener, U. Does adjuvant antibiotic treatment after drainage of anorectal abscess prevent development of anal fistulas? / U. Sözener, E. Gedik, A.A. Kessaf, et al. // Dis Colon rectum. – 2011. – №54. – p. 923-929.

  47. He, J. Efficacy of surgical treatment of perianal infection in patients with hematological malignancy / J. He, Z. Ni, Z. Li. // Medicine (Baltimore). – 2024. – №103(19). – e38082.

  48. Mocanu, V. Antibiotic use in prevention of anal fistulas following incision and drainage of anorectal abscesses: A systematic review and meta-analysis / V. Mocanu, J.T. Dang, F. Ladak, et al. // Am J Surg. – 2019. – №217(5). – p. 910-917.

  49. Afşarlar, Ç. Perianal abscess and fistula-in-ano in children: clinical characteristic, management and outcome / Ç.E. Afşarlar, A. Karaman, G. Tanır, et al. // Pediatr Surg Int. – 2011. – №10. – p. 1063-1068.

  50. Chakarov, D. Aerobic Microbiological Spectrum and Antibiotic Resistance in Children Operated for Anorectal Abscesses /  D. Chakarov, E. Hadzhieva, Y. Kalchev, D. Hadzhiev // J Clin Med. – 2024. – №13(8) – 2414.

  51. Smith, S.R. Internal dressings for healing perianal abscess cavities / S.R. Smith,  K. Newton, J.A. Smith, et al. // Cochrane Database Syst Rev. – 2016. – №26(8). 

  52. Malik, A.I. Incision and drainage of perianal abscess with or without treatment of anal fistula / A.I. Malik, R.L. Nelson, S. Tou // Cochrane Database of Systematic Reviews. – 2010. – Issue 7. – Art. No.: CD006827.

  53. Galanis, I. Prospective Randomized Trial of Simple Drainage vs. Drainage and Initial Fistula Management for Perianal Abscesses / I. Galanis, G. Chatzimavroudis, P. Christopoulos, J. Makris // J Gastrointest Dig Syst. – 2016. – №6. – р. 382.

  54. Ding, C. Risk factors for therapy failure after incision and drainage alone for perianal abscesses in children / C. Ding, Y. Chen, J. Yan, et al. // Front Pediatr. – 2024. – №8(12) – 1342892.

  55. Bałaż, K. Perianal abscess and fistula-in-ano in children - evaluation of treatment efficacy. Is it possible to avoid recurrence? / K. Bałaż, A. Trypens, D. Polnik, et al. // Pol Przegl Chir. – 2020. –№92(2). – p. 29-33.

  56. Sun, Y. A Systematic Review and Meta-Analysis of Comparing Drainage Alone versus Drainage with Primary Fistula Treatment for the Perianal Abscess in Children / Y. Sun, S. Hao, X. Zhang, et al. // Eur J Pediatr Surg. – 2024. – №34(3). – p. 204-214.

  57. Badgwell, B.D. Management and outcomes of anorectal infection in the cancer patient / B.D.  Badgwell, G.J. Chang, M.A. Rodriguez-Bigas, et al. // Ann Surg Oncol. – 2009. – №16. – р. 2752–2758.

  58. Büyükaşik, Y. Perianal infections in patients with leukemia: importance of the course of neutrophil count / Y. Büyükaşik, O.I. Ozcebe, N. Sayinalp, et al. // Dis Colon Rectum. – 1998. – №41. – р. 81–85.

  59. Shtyrkova, S.V. Perianal'naya infektsiya u bol'nykh gemoblastozami: faktory riska i vozmozhnosti profilaktiki / S.V. Shtyrkova, G.A. Klyasova, K.I. Danishyan, E.G. Gemdzhyan i soavt. // Terapevticheskiy arkhiv. – 2016. – №7. – s. 72-77.

  60. Morcos, B. Contemporary management of perianal conditions in febrile neutropenic patients. / B. Morcos, R. Amarin, A. Abu Sba, R. Al-Ramahi, et al. // Eur. J. Surg. Oncol. – 2013. – №39(4). – p. 404–407.

  61. Solmaz, S. Anorectal Complications During Neutropenic Period in Patients with Hematologic Diseases / S. Solmaz, A. Korur, Ç. Gereklioğlu, S. Asma, et al. // Mediterr J Hematol Infect Dis. – 2016. – №8(1). – e2016019.

  62. Shtyrkova, S.V. Diagnostika i lechenie slozhnykh form ostrogo paraproktita u patsientov s opukholevymi zabolevaniyami sistemy krovi / S.V. Shtyrkova, O.A. Soboleva, K.R. Sabirov i soavt. // Koloproktologiya. – 2024. – T. 23, № 1(87). – s. 117-128.

  63. Renzi, S. Perianal Infections in Children With Acute Myeloid Leukemia: A Report From the Canadian Infection in Acute Myeloid Leukemia Research Group / S. Renzi, J. Bartram, S. Ali, et al. // J Pediatric Infect Dis Soc. – 2019. – №8(4). – p. 354-357.

Appendix A1. Working Group Composition

№

Full Name

Academic degree

Academic title

Professional association

1.                   

Akselrov, Mikhail Aleksandrovich

Doctor of Medical Sciences

Associate Professor

Association of Coloproctologists of Russia

Russian Association of Pediatric Surgeons

2.                   

Fuad Sh. Aliev

Doctor of Medical Sciences

Professor

Association of Coloproctologists of Russia

3.                   

Amirova, Amina Khadzimuradovna

Association of Coloproctologists of Russia

4.                   

Sergey I. Achkasov

Doctor of Medical Sciences

Corresponding Member of the RAS, Professor

Association of Coloproctologists of Russia

5.                   

Vitaly S. Groshilin

Doctor of Medical Sciences

Professor

Association of Coloproctologists of Russia

6.                   

Egorkin, Mikhail Aleksandrovich

Doctor of Medical Sciences

Association of Coloproctologists of Russia

7.                   

Ilkanich Andrey Yanoshevich

Doctor of Medical Sciences

Professor

Association of Coloproctologists of Russia

8.                   

Kashnikov Vladimir Nikolayevich

Doctor of Medical Sciences

Association of Coloproctologists of Russia

9.                   

Ivan V. Kostarev

Doctor of Medical Sciences

Associate Professor

Association of Coloproctologists of Russia

10.               

Kostenko Nikolai Vladimirovich

Doctor of Medical Sciences

Professor

Association of Coloproctologists of Russia

11.               

Kotin, Aleksey Nikolaevich

Candidate of Medical Sciences

Associate Professor

Association of Coloproctologists of Russia

Russian Association of Pediatric Surgeons

12.               

Kuzminov, Aleksandr Mikhailovich

Doctor of Medical Sciences

Professor

Association of Coloproctologists of Russia

13.               

Lukyanov Anton Sergeevich

Candidate of Medical Sciences

Association of Coloproctologists of Russia

14.               

Morozov, Dmitriy Anatolevich

Doctor of Medical Sciences

Professor

Association of Coloproctologists of Russia

Russian Association of Pediatric Surgeons

15.               

Aleksey I. Moskalev

Candidate of Medical Sciences

Association of Coloproctologists of Russia

16.               

Muravyev Alexander Vasilyevich

Doctor of Medical Sciences

Professor

Association of Coloproctologists of Russia

17.               

Novozhilov, Vladimir Aleksandrovich

Doctor of Medical Sciences

Associate Professor

Association of Coloproctologists of Russia, Russian Association of Pediatric Surgeons

18.               

Igor A. Nechay

Doctor of Medical Sciences

Professor

Association of Coloproctologists of Russia

19.               

Popov Dmitry Evgenievich

Candidate of Medical Sciences

Associate Professor

Association of Coloproctologists of Russia

20.               

Razumovskiy, Aleksandr Yuryevich

Doctor of Medical Sciences

Corresponding Member of the RAS,

Professor

Association of Coloproctologists of Russia

21.               

Svarich, Vyacheslav Gavrilovich

Doctor of Medical Sciences

Associate Professor

Association of Coloproctologists of Russia

Russian Association of Pediatric Surgeons

22.               

Stepanova, Natalya Maratovna

Candidate of Medical Sciences

Associate Professor

Association of Coloproctologists of Russia

Russian Association of Pediatric Surgeons

23.               

Titov Alexander Yuryevich

Doctor of Medical Sciences

Association of Coloproctologists of Russia

24.               

Frolov Sergey Alekseevich

Doctor of Medical Sciences

Professor

Association of Coloproctologists of Russia

25.               

Shelygin Yury Anatolyevich

Doctor of Medical Sciences

Academician of the RAS, Professor

Association of Coloproctologists of Russia

26.               

Shtyrkova, Svetlana Vitalievna

Candidate of Medical Sciences

Association of Coloproctologists of Russia

27.               

Shcherbakova, Olga Vyacheslavovna

Doctor of Medical Sciences

Association of Coloproctologists of Russia

Russian Association of Pediatric Surgeons

All members of the working group are members of the Association of Coloproctologists of Russia. There is no conflict of interest.

Appendix A2. Methodology for Developing Clinical Guidelines

Target audience of the clinical guidelines:

1. Coloproctologists

2. Surgeons

3. Pediatric surgeons

4. Gastroenterologists

5. General physicians / Internists

6. General practitioners (family physicians)

7. Endoscopists

8. Mid-level medical professionals

9. Healthcare organizers

10. Expert physicians of medical insurance organizations (including when conducting medical and economic expertise)

11. Medical university students, residents, postgraduate students.

In these clinical guidelines, all data are ranked by level of reliability (evidence) depending on the quantity and quality of studies on the issue.

Table 1. Scale for grading levels of evidence (LE) for diagnostic methods (diagnostic interventions)

LoE

Definition

1

Systematic reviews of studies with reference standard control or systematic reviews of randomized controlled trials with meta-analysis

2

Individual studies with reference method control or individual randomized clinical trials and systematic reviews of studies of any design, except for randomized clinical trials with meta-analysis

3

Studies without consecutive reference standard control or studies with a reference standard not independent of the test method, or non-randomized comparative studies, including cohort studies

4

Non-comparative studies, case report

5

There is only a rationale for the mechanism of action or expert opinion

Table 2. Scale for grading levels of evidence (LE) for prevention, treatment, and rehabilitation methods (preventive, therapeutic, and rehabilitative interventions)

LoE

Definition

1

Systematic review of randomized controlled trials with meta-analysis

2

Individual randomized controlled trials and systematic reviews of studies of any design, except randomized controlled trials, with meta-analysis

3

Non-randomized comparative studies, including cohort studies

4

Non-comparative studies, case reports or case series, case-control studies

5

Only justification of the mechanism of action of the intervention (preclinical studies) or expert opinion is available

Table 3. Grading of grades of recommendations (GR) for preventive, diagnostic, therapeutic, and rehabilitation methods (interventions)

Level of Evidence / Strength of Recommendation

Definition

A

Strong recommendation (all considered efficacy criteria (outcomes) are important, all studies are of high satisfactory methodological quality, and their conclusions regarding the outcomes of interest are consistent)

C

Conditional recommendation (not all considered efficacy criteria (outcomes) are important, not all studies are of high satisfactory methodological quality and/or their conclusions regarding the outcomes of interest are inconsistent)

C

Weak recommendation (lack of adequate quality evidence (all considered efficacy criteria (outcomes) are unimportant, all studies are of low methodological quality, and their conclusions on the outcomes of interest are inconsistent)

Procedure for updating clinical guidelines

The mechanism for updating clinical guidelines provides for systematic revision at least once every three years, as well as upon the emergence of new evidence-based medicine data regarding the diagnosis, treatment, prevention, and rehabilitation of specific diseases, or in the presence of justified additions/comments to previously approved clinical guidelines, but no more frequently than once every 6 months.

Appendix A3. Reference Materials

Related documents

These clinical guidelines were developed taking into account the following regulatory legal documents:

1. Clause 3 of Article 37 of Federal Law No. 323-FZ of the Russian Federation dated November 21, 2011, “On the Fundamentals of Protecting the Health of Citizens in the Russian Federation” (as amended and supplemented, effective January 11, 2023);

2. Order of the Ministry of Health of the Russian Federation No. 203n dated May 10, 2017, “On Approval of Criteria for Assessing the Quality of Medical Care”;

3. Order of the Ministry of Health of the Russian Federation No. 206n dated April 2, 2010 (as amended on February 21, 2020) “On Approval of the Procedure for Providing Medical Care to the Population with Coloproctological Diseases of the Colon, Anal Canal, and Perineum”;

4. Order of the Russian Ministry of Health No. 71n dated February 11, 2022, "On Approval of the Standard of Medical Care for Adults with Acute Paraproctitis (Diagnosis and Treatment)".

Appendix B. Physician Action Algorithms

Appendix B. Physician Action Algorithms — Acute Paraproctitis

Appendix C. Patient Information

Acute paraproctitis is an acute purulent-inflammatory disease of the pararectal adipose tissue. Infection from the rectum via the anal gland ducts can rapidly spread into one of the pararectal spaces — subcutaneous (most commonly), ischioanal, pelvirectal, or retrorectal (very rarely).

The forms of acute paraproctitis are named after these spaces: submucosal, subcutaneous, ischioanal, pelvirectal (pelvirectal space abscess), and retrorectal. An intersphincteric abscess is sometimes distinguished, but this term is better used in chronic paraproctitis, as it is difficult to precisely localize the abscess cavity during an acute process. The internal opening of the abscess is almost always single, while there may be two or more external openings, and these external abscesses are often located on both sides of the anus — posteriorly or anteriorly to the rectum (horseshoe paraproctitis). The "arch" of such an abscess passes posteriorly, between the anus and the coccyx (most commonly) or anteriorly to the anus (in women, between the anus and the rectovaginal septum). Accordingly, posterior or anterior horseshoe acute paraproctitis is diagnosed, and the abscess may be subcutaneous on one side and ischioanal on the other, etc. Most commonly, in more than half of all patients, the abscess is located at the border of the skin and mucosa — subcutaneous-submucosal marginal acute paraproctitis.

The clinical presentation of acute paraproctitis is typical of any pararectal suppuration: swelling, tenderness upon palpation, pain that is increasing or sometimes sudden, worsening with walking and sitting, coughing, or defecation (not always), and softening in the center. General condition worsens, and low-grade fever appears. The general condition suffers most with deep (ischioanal, pelvirectal) abscesses, while local changes in these forms of abscess are minimal — there is almost no skin redness, and only deep thrusting with the fingertips elicits pain on the affected side.

With deep (high) ischioanal, pelvirectal, or retrorectal acute paraproctitis, the patient's general condition may be severe (high fever, all signs of intoxication, deep pelvic pain), while local changes may sometimes be unimpressive.

Anal fistulas frequently develop after drainage of acute paraproctitis.

The decision on whether to perform a specific radical surgery for acute paraproctitis should be made exclusively by a specialist coloproctologist. When such a patient is admitted to a general surgery department, the abscess in the perineum should simply be widely opened and drained, and the patient warned about the potential recurrence of the abscess or the formation of a rectal fistula. If this occurs, the patient should be referred for elective surgery to a coloproctology department.

Following abscess drainage, it is preferable to subsequently perform a qualified elective surgery for anal fistula in a coloproctology clinic rather than attempting by any means to radically operate on acute paraproctitis in a single stage without regard for the future function of the sphincter apparatus.

Complete recovery occurs with timely surgical treatment. In cases of inadequate drainage, lack of treatment, or chronic infection, a fistulous tract forms as a consequence of paraproctitis.

Sometimes fistulous tracts facilitate the spread of inflammation into hard-to-reach areas of the lesser pelvis. As a result, the infection becomes impossible to eliminate completely. This provokes constant recurrences of paraproctitis. A prolonged course of the disease can cause adhesive processes in the lesser pelvis and scarring changes in the walls of the anal canal.

Prevention consists of the timely treatment of rectal diseases and compliance with personal hygiene. Prompt surgical treatment of the acute phase of the disease prevents the formation of anal fistulas. An important factor in preventing the condition is the normalization of bowel function.

Appendix G. Assessment Scales, Questionnaires, and Other Evaluation Tools

No.

If you practice in the specialty of pediatric surgery

ClinRevs Pro690 ₽ per month · cancel anytime

Clinical calculators and scalesRisk calculation, dosing, and scoring using scales from clinical guidelines — online, no registration required.

Open calculators

Answers based on Russian clinical guidelines right in ChatGPT and Claude Connect the WhiteCoat Pro connector, and the assistant will answer based on the "Acute Paraproctitis" guideline and other active Russian Ministry of Health clinical guidelines with references to the specific section, rather than retelling foreign guidelines. Address: mcp.pervoklassno.ru/mcp. How to configure ChatGPT, Claude, Gemini, and Perplexity for Russian clinical guidelines

Subscribe in 2 minutes

AI Research DigestEvery morning — fresh PubMed articles in your specialty: translation, AI analysis, and link to the original. Reads in four minutes.

Subscribe for 990 ₽

Related clinical guidelines